Dysregulated cysteine metabolism leads to worsened liver pathology in diabetes-tuberculosis comorbid condition
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.105634 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Shweta Chaudhary und 2 weiteren Autor:innen. Beteiligte Einrichtung: Translational Health Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Tuberculosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: International Centre for Genetic Engineering and Biotechnology, European Molecular Biology Organization, Department of Biotechnology, Ministry of Science and Technology, India.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus (DM) is a risk factor for developing active tuberculosis (TB) with a 3-fold increase in susceptibility and a 4-fold higher relapse rate. With increasing DM prevalence in TB endemic regions, understanding pathophysiological changes associated with DM-TB comorbidity is imperative. In this study, streptozotocin (STZ)-induced DM C57BL/6 mice were aerosol infected with low dose (100-120 CFU) Mycobacterium tuberculosis H37Rv. At 3 weeks post infection (w.p.i.), multiple tissue mycobacterial load and metabolites were profiled. The liver proteome of DM-TB and controls were analyzed using quantitative proteomics, and multi-omics data were integrated. DM-TB mice showed dysregulated multi-tissue (lungs, liver, brain, kidney and thigh muscle) metabolism. In contrast, the mycobacterial burden in the lung, spleen and liver was similar at 3 w.p.i. in DM-TB and TB groups. Enrichment analysis of deregulated liver metabolites (n = 20; log2DM-TB/TB>±1.0) showed significant perturbation in cysteine-methionine, glycine-serine, BCAA and fatty acid metabolism. 60 out of 1660 identified liver proteins showed deregulation (log2DM-TB/TB>±1.0) and contributed from perturbed cysteine-methionine metabolism corroborating metabolomics data. In addition, amino acid biosynthesis, retinol metabolism and polyol biosynthetic process were also differentially enriched in the livers of DM-TB groups. Global correlation analysis of liver metabolome and proteome data showed a strong association between aspartic acid, pyruvic acid, leucine and isoleucine with CYP450 enzymes involved in retinol metabolism, while iminodiacetic acid, isoleucine and γ-aminobutyric acid (GABA) strong positive correlation involved in cysteine metabolism. Targeting perturbed cysteine metabolism using micro molecules, like DL-Propargylglycine, might help prevent liver damage in DM-TB comorbid conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Health Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
- Translational Health Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India. Electronic address: ranjan@icgeb.res.in.
Förderung
- International Centre for Genetic Engineering and Biotechnology
- European Molecular Biology Organization
- Department of Biotechnology, Ministry of Science and Technology, India
- Council of Scientific and Industrial Research, India
Zitieren
APA
Chaudhary, S., Pahwa, F., & Nanda, R. K. (2024). Dysregulated cysteine metabolism leads to worsened liver pathology in diabetes-tuberculosis comorbid condition. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.105634
Vancouver
Chaudhary S, Pahwa F, Nanda RK. Dysregulated cysteine metabolism leads to worsened liver pathology in diabetes-tuberculosis comorbid condition. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.105634
BibTeX
@article{Chaudhary2024,
author = {Chaudhary, Shweta and Pahwa, Falak and Nanda, Ranjan K},
title = {Dysregulated cysteine metabolism leads to worsened liver pathology in diabetes-tuberculosis comorbid condition},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.105634}
}
EUVIMED